Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAP2: Treatment of Stage 1 Hypertension in Pregnancy
NCT05989581Phase 1Recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of labetalol and nifedipine GITS in gestational hypertension (GH) (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Neonatal Birthweight percentile. Started Apr 2024; status: recruiting.
02
Drugs
labetalolnifedipine GITS
03
Conditions
gestational hypertension (GH)
Beyond the preview
Go deeper on NCT05989581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05989581.